AMYLGEN/NEURON-EXPERTS
Amylgen and Neuron-Experts, two leading preclinical CROs specialized in CNS pathologies, today announced an exclusive and strategic partnership that combines their respective in-vivo and in-vitro expertise to provide a new offering for a rapid efficacy assessment of compounds in neurodegenerative diseases.
Under this agreement, Amylgen and Neuron-Experts, who both serve biotechnology, pharmaceutical and nutraceutical companies as part of their preclinical development for CNS pathologies, will jointly provide customers with a new, rapid and comprehensive offering to evaluate on in-vitro and in-vivo models the efficacy of compounds in neurodegenerative diseases. This new preclinical offering will provide a first efficacy proof of concept to select the most effective compound among several leads. Subsequent studies will be possible to further investigate the therapeutical benefit, the elucidation of action mecanism, the therapeutical strategy...
“Helping our clients achieve their strategic preclinical objectives is our core focus and we continue to build out our suite of services and partnerships to support that mission, ” said Vanessa Villard, CEO, Amylgen. “In Neuron-Experts, we chose a partner who not only provides best-in-class expertise in CNS in-vitro testing, but also shares our deep commitment to ensuring mutual clients have access to the most comprehensive and effective solutions to evaluate the clinical potential of their compounds. ”
“As a trusted partner to biotech companies for their preclinical development in neurodegenerative diseases, we believe in the great value to offer a rapid efficacy assessment of new compounds combining in-vitro and in-vivo testing as a primary proof of concept. We are honored to be partnered with Amylgen, a respected and innovative in-vivo preclinical CRO, to launch this new offering and together we look forward to delivering significant value to our clients, ” said Remy Steinschneider, CEO, Neuron-Experts.
Amylgen will market this joint offering, that will be launched as a first step to assess the efficacy of compounds on Alzheimer’s Disease . The offer will be rapidly extended to other neurodegenerative diseases.
About Neuron-Experts
Neuron Experts is a Contract Research Organization (CRO) specialized in the in-vitro study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modelling neurodegenerative diseases and neuronal impairment-induced skin disorders.
About Amylgen
Amylgen is a privately held preclinical CRO offering a unique combination of validated in-vivo rodent models and a full range testing allowing fast and predictive screening of the effects of drugs and nutraceuticals on brain health. Thanks to background in the Industry, we guarantee satisfaction and provide our services with nonconditional high quality standards and with full awareness of time sensitive deadlines in the frame of critical phases of your product development.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191211005399/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Reports First Quarter 2025 Results6.5.2025 22:35:00 CEST | Press release
IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2025. Management Commentary “IFF delivered solid first quarter results, driven by disciplined execution and broad-based growth across most of our business,” said IFF CEO Erik Fyrwald. “Our growth, combined with ongoing productivity initiatives, contributed to a meaningful increase in profitability. We also successfully completed the divestiture of our Pharma Solutions business two months ahead of schedule, a key milestone that supports the achievement of our targeted debt leverage ratio." “As we navigate the heightened macroeconomic uncertainty in today’s environment, we remain focused on what we can control - collaborating with our customers to drive growth, investing in innovation and delivering increased productivity. We are maintaining our full-year financial guidance ranges but recognize that the uncertain environment has potential for more challenges, yet we remain confident in our long-term strategy
Lattice to Showcase Advanced Edge AI Solutions at New-Tech 2025 Exhibition6.5.2025 22:00:00 CEST | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it will showcase its latest FPGA technology at the New-Tech 2025 Exhibition. Lattice technology demos will be featured in the Telsys Ltd. booth, showcasing industry-leading low power, small form factor FPGAs and application-specific solutions enabling advanced embedded vision, artificial intelligence, and sensor fusion capabilities. Additionally, Lattice will deliver a technical presentation titled “Power-Efficient Robotics and Automation Fueled by Lattice FPGA Technology” about how advanced, power-optimized FPGAs can dramatically reduce power consumption for next-generation automation and robotics solutions for Industrial applications. Who: Lattice Semiconductor What / When: May 20 – 21: Lattice demo showcase (Telsys Ltd. Booth #67-68) May 21, 10:20 a.m.: “Power-Efficient Robotics and Automation Fueled by Lattice Semiconductor FPGA Technology” technical presentation Where: New-Tech 2025 Exhib
Rockstar Games Releases Trailer 2 for Grand Theft Auto VI6.5.2025 18:37:00 CEST | Press release
Explore Vice City and beyond at rockstargames.com/VI Rockstar Games®, a publishing label of Take-Two Interactive Software, Inc. (NASDAQ: TTWO), is proud to announce the release of Trailer 2 for Grand Theft Auto VI, alongside a closer look at the biggest, most immersive evolution of the series yet: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506495901/en/ Set to launch on May 26, 2026, on PlayStation® 5 computer entertainment systems and Xbox Series X|S games and entertainment systems, Grand Theft Auto VI will soon be available for wishlisting on both the PlayStation and Microsoft Stores. Vice City, USA. Jason and Lucia have always known the deck is stacked against them. But when an easy score goes wrong, they find themselves on the darkest side of the sunniest place in America, in the middle of a criminal conspiracy stretching across the state of Leonida — forced to rely on each other more than ever if they want to mak
Monroe Capital, SMBC and MA Financial Launch US$1.7 Billion Middle Market Lending Joint Venture6.5.2025 16:07:00 CEST | Press release
Monroe Capital, Sumitomo Mitsui Banking Corporation (SMBC) and MA Asset Management (part of MA Financial Group, ASX: MAF) today announced the formation of a new joint venture (“JV”), which will invest up to US$1.7 billion in senior secured loans to U.S. middle market borrowers. The JV harnesses the complementary capabilities of the three partnering institutions to establish a differentiated platform focused on the attractive middle market subset of private credit. The JV expects to benefit from broad access to high-quality, proprietary deal flow of first-lien senior-secured loans to established middle market companies, leveraging the loan origination capabilities of Monroe Capital’s direct lending infrastructure, SMBC’s established private credit and sponsor finance platform and MA Financial’s expertise in specialty credit and co-lending. The JV’s investable capital will be provided by Monroe Capital, SMBC and MA Financial (via its managed funds). Monroe Capital is one of the largest l
Sentry Acquires Emerge Tools to Help Developers Ship Better, Faster Mobile Apps6.5.2025 15:00:00 CEST | Press release
Emerge’s suite of tools will help Sentry build the most complete mobile app monitoring solution on the market Sentry, the leading debugging platform for developers, today announced it has acquired Emerge Tools, a prominent provider of mobile app development solutions. Emerge Tools enables teams to deliver smaller, faster and more reliable mobile apps. Its platform powers visual regression testing at OpenAI and app size monitoring at Spotify. Companies like DoorDash have used Emerge to improve app launch speed by 60%, while Duolingo used Emerge to help delete thousands of lines of unnecessary code. According to Statista, “mobile applications are projected to generate more than 613 billion dollars in revenue in 2025”. In a fast growing mobile app landscape, slow loading times, excessive battery drain, and UI instability can lead to negative user sentiment and app abandonment. Emerge Tools directly addresses these challenges by giving developers the ability to proactively identify and res
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom